China Drug Delivery Devices Market Size (2024 - 2029)

China Drug Delivery Devices Market Analysis

The China Drug Delivery Devices Market is expected to register a CAGR of 9.21% during the forecast period.

The major factors contributing to the growth of the Chinese drug delivery devices market are the growing burden of chronic diseases such as cerebrovascular diseases, cancer, chronic respiratory diseases, and diabetes, as well as the technological advancements in drug delivery devices. Due to the rising burden of chronic diseases, drug delivery systems are being frequently used to enhance patient health and treatment outcomes. For instance, as per the data published by the International Agency for Research on Cancer in February 2024, the estimated number of new cancer cases in China was 4.82 million in 2022, which is expected to reach 5.13 million by 2025. There is a gradual rise in the incidence of cancer in China, which is expected to increase demand for delivery devices such as prefilled syringes and autoinjectors during the forecast period.

Furthermore, training on drug delivery device usage is expected to increase the use of these devices in hospitals, which is expected to drive market growth over the forecast period. For instance, in August 2023, Dongguan Songshan Lake Donghua Hospital stated that it had started a new technology training course for upper arm implantable drug delivery devices in Dongguan. This initiative is expected to increase the number of trained staff in hospitals, which may increase the usage of these devices and boost market growth over the forecast period.

The strategic activities of the market players, such as product launches, mergers and acquisitions, and partnerships, are expected to boost the market's growth over the forecast period. For instance, in January 2024, Suzhou Saiwei Biotechnology Co. Ltd signed a strategic cooperation agreement with Borri Pharmaceuticals. With this agreement, the two companies cooperate on the production and supply of automatic injection pens, which is expected to increase the availability of these drug delivery devices, thereby boosting the market growth over the forecast period.

Thus, all the factors above, such as the rising prevalence of chronic diseases and strategic activities by market players, are expected to boost the market growth over the forecast period. However, the high development cost for drug delivery devices is expected to restrain market growth over the forecast period.

China Drug Delivery Devices Industry Overview

As per the scope of the report, drug delivery devices are specialized tools for delivering a drug or therapeutic agent via a specific route of administration.

The Chinese drug delivery devices market is segmented by device type, therapeutic application, and sales channel. By device type, the market is segmented into nasal, implantable, injectable, and other device types. The nasal segment includes inhalers and other device types. The injectable segment includes conventional drug delivery devices and self-injectable drug delivery devices. Self-injectable drug delivery devices include prefilled syringes, auto-injectors, and other self-injectable drug delivery devices. The other device types include droppers and sprays. By therapeutic application, the market is segmented into cardiovascular, oncology, autoimmune disorder, pulmonary disease, and other therapeutic applications. Other therapeutic applications include metabolic diseases, infectious diseases, and others. By sales channel, the market is segmented into hospitals, pharmacies, and other sales channels. The other sales channels include clinics, ambulatory centers, and others. The report offers market sizes and forecasts in terms of value (USD) for the above segments.